Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2024/07/17/3-biotech-stocks-you-should-know-about

7/17/2024 2:35 PM

In June, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month. XBI proceeded to rattle off a 4% win for June and is up 7.3% in July already. Wh...

Puts Pop as EXAS Heads For Worst Day in 16 Months

https://www.schaeffersresearch.com/content/news/2020/01/13/puts-pop-as-exas-heads-for-worst-day-in-16-months

1/13/2020 10:05 AM

The shares of EXACT Sciences Corporation (NASDAQ:EXAS) are down 11.4% to trade at $92.52 this morning, after the molecular diagnostics specialist gave its preliminary fourth-quarter revenue results. ...

Global Growth Concerns Pressure Dow Futures

https://www.schaeffersresearch.com/content/ezines/2019/09/23/global-growth-concerns-pressure-dow-futures

9/23/2019 9:13 AM

Futures on the Dow Jones Industrial Average (DJI) are churning below fair value this morning, as disappointing manufacturing data out of Germany reignites concerns of a slowing global economy. Data...

More Bull Notes for EXACT Sciences After Earnings

https://www.schaeffersresearch.com/content/news/2019/05/01/more-bull-notes-for-exact-sciences-after-earnings

5/1/2019 9:55 AM

Molecular diagnostics specialist EXACT Sciences Corporation (NASDAQ:EXAS) has received a number of bullish analyst notes this morning after the company's earnings release last night. Canaccord Genuit...

Exact Sciences Stock On Track for Best Day In Over a Year After Pfizer Deal

https://www.schaeffersresearch.com/content/news/2018/08/22/exact-sciences-stock-on-track-for-best-day-in-over-a-year-after-pfizer-deal

8/22/2018 10:13 AM

EXACT Sciences Corporation (NASDAQ:EXAS) stock is jumping today, after the healthcare company secured a marketing deal with Pfizer (PFE) for its stool screening test to help detect colorectal cancer....

PEOPLE ALSO SEARCH FOR